abstract |
A pharmaceutical composition comprising (2S, 3R, 4R, 5S, 6R) -2- (4-chloro-3- (4-ethoxybenzyl) phenyl) -6- (methylthio) tetrahydro-2H-pyran-3,4,5 crystalline anhydroustriol, in which the (2S, 3R, 4R, 5S, 6R) -2- (4-chloro-3- (4- ethoxybenzyl) phenyl) -6- (methylthio) tetrahydro-2H-pyran-3 , Anhydrous crystalline 4,5-triol has an endotherm of DSC at 124 ° C ± 5.0 ° C or 134 ° C ± 5.0 ° C. |